News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Large Allergan Inc. (AGN) Investor Sells Most Of Stake



7/21/2014 7:54:29 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Allergan's largest holder as of the end of March, Capital Research and Management, has sold nearly all of its stake in the company, The Wall Street Journal reported Monday. According to people close to the matter, Capital Research and Management sold the shares, representing a 6.3-percent stake, after meeting with Allergan CEO David Pyott. Sources noted that the sale indicates that Capital Research and Management didn't see Allergan's share price rising much above Valeant Pharmaceuticals' $53-billion hostile offer.

Hey, check out all the research scientist jobs. Post your resume today!



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES